Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3772309012 | Amylase and endopeptidase and pancreatic lipase only product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3772310019 | Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | Is a | Product containing only amylase and endopeptidase and pancreatic lipase (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | Is a | Product containing only amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | Is a | Product containing amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | Has active ingredient | Amylase | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | Has active ingredient | Endopeptidase | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | Has active ingredient | Pancreatic lipase | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | Plays role | Digestant therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) | Is a | True | Product containing only amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR